First and second seizure: What to know and do

Food Insecurity and the Dangers of Infant Formula Dilution

In the study through 76 weeks, no new risks were observed with once-daily upadacitinib (15 mg or 30 mg).

January 30th 2023

A preview of the November/December issue of Contemporary Pediatrics

Tina Q Tan, MD, FAAP, FIDSA, FPIDS

Demystifying Infant Formula

Editor-in-chief Tina Tan, MD, FAAP, FIDSA, FPIDS, highlights the final Contemporary Pediatrics journal of the year.

October 11th 2022

Survey: titrating trofinetide improves tolerability among Rett syndrome patients

Survey: trofinetide improves tolerability among Rett syndrome patients | Image Credit: © ARBA - © ARBA - stock.adobe.com.

Weekly review: COVID-19 roundtable, upadacitinib data for AD, and more

Respondents reported decreased diarrhea severity, improved patient quality of life, and decreased treatment discontinuation among patients with Rett syndrome treated with trofinetide.

Weekly review: COVID-19 roundtable discussion, migraine prevention, and more | Image Credit: © Artur - © Artur - stock.adobe.com.

Upadacitinib effective in treating atopic dermatitis through 76 weeks

Get caught up with Contemporary Pediatrics! This list helps you navigate our top stories from the week, all in one place.

Related Content

Food Insecurity and the Dangers of Infant Formula Dilution

In the study through 76 weeks, no new risks were observed with once-daily upadacitinib (15 mg or 30 mg).

January 30th 2023

A preview of the November/December issue of Contemporary Pediatrics

Tina Q Tan, MD, FAAP, FIDSA, FPIDS

Demystifying Infant Formula

Editor-in-chief Tina Tan, MD, FAAP, FIDSA, FPIDS, highlights the final Contemporary Pediatrics journal of the year.

October 11th 2022

Survey: titrating trofinetide improves tolerability among Rett syndrome patients

Weekly review: COVID-19 roundtable, upadacitinib data for AD, and more

Respondents reported decreased diarrhea severity, improved patient quality of life, and decreased treatment discontinuation among patients with Rett syndrome treated with trofinetide.